Effect of P-glycoprotein inhibition on methadone analgesia and brain distribution in the rat (original) (raw)

Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties

marianne seleman

Psychopharmacology, 2014

View PDFchevron_right

Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice

Salvatore Cisternino

Pharmaceutical research, 2001

View PDFchevron_right

Lack of evidence for involvement of P-glycoprotein in brain uptake of the centrally acting analgesic, tramadol in the rat

Behjat Sheikholeslami

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques, 2012

View PDFchevron_right

Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds – implications for pharmacokinetics of selected substrates

amal sebastian

Journal of Pharmacy and Pharmacology, 2004

View PDFchevron_right

Antiepileptic drugs modulate P-glycoproteins in the brain: A mice study with 11C-desmethylloperamide

Lieselotte Moerman, Robrecht Raedt

Epilepsy Research, 2011

View PDFchevron_right

The role of P-glycoprotein in blood-brain barrier transport of morphine: transcortical microdialysis studies inmdr1a(−/−) andmdr1a(+/+) mice

Elizabeth CM de Lange

British Journal of Pharmacology, 1999

View PDFchevron_right

PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS

Aren van Waarde

2004

View PDFchevron_right

The role of P‐glycoprotein in blood‐brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (−/−) and mdr1a (+/+) mice

Elizabeth CM de Lange

British journal of …, 1999

View PDFchevron_right

P-glycoprotein Modulates Morphine Uptake into the CNS: A Role for the Non-steroidal Anti-inflammatory Drug Diclofenac

Thomas Davis

PLoS ONE, 2014

View PDFchevron_right

The transport of antiepileptic drugs by P-glycoprotein

Larry Baum

Advanced Drug Delivery Reviews, 2012

View PDFchevron_right

Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine

Juergen Drewe

British Journal of Clinical Pharmacology, 2000

View PDFchevron_right

Opioid Transport by ATP-Binding Cassette Transporters at the Blood-Brain Barrier: Implications for Neuropsychopharmacology

Salvatore Cisternino

Current Pharmaceutical Design, 2011

View PDFchevron_right

P-glycoprotein Interactions of Novel Psychoactive Substances - stimulation of ATP consumption and transport across Caco-2 Monolayers

Hans Maurer

Biochemical pharmacology, 2015

View PDFchevron_right

Pharmacokinetics of P-glycoprotein inhibition in the rat blood-brain barrier

Obaidur Rahman

Journal of Pharmaceutical Sciences, 2008

View PDFchevron_right

Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure

L. Cohen, Gino Salituro

Xenobiotica, 2009

View PDFchevron_right

THE ROLE OF THE POLYMORPHIC EFFLUX TRANSPORTER P-GLYCOPROTEIN ON THE BRAIN ACCUMULATION OF d-METHYLPHENIDATE AND d-AMPHETAMINE

Haojie Zhu

View PDFchevron_right

G protein-coupled receptor (GPCR) trafficking in the central nervous system: relevance for drugs of abuse

Wes Kroeze

Drug and Alcohol Dependence, 1998

View PDFchevron_right

The effect of quinidine, a strong P‐glycoprotein inhibitor, on the pharmacokinetics and central nervous system distribution of naloxegol

Khanh bui

The Journal of Clinical Pharmacology, 2015

View PDFchevron_right

Species Comparison of In Vivo P-Glycoprotein-Mediated Brain Efflux Using mdr1a-Deficient Rats and Mice

Christoffer Bundgaard

Drug Metabolism and Disposition, 2012

View PDFchevron_right

P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexone

Youssef Daali

Fundamental & Clinical Pharmacology, 2009

View PDFchevron_right

In-vitro respiratory drug absorption models possess nominal functional P-glycoprotein activity

Pavel Dolezal

Journal of Pharmacy and Pharmacology, 2009

View PDFchevron_right

Effect of chronic exposure to morphine on the rat blood-brain barrier: focus on the P-glycoprotein

Bruno Saubaméa

Journal of Neurochemistry, 2008

View PDFchevron_right

In Vitro P-glycoprotein Assays to Predict the in Vivo Interactions of P-glycoprotein with Drugs in the Central Nervous System

selene maia de morais

Drug Metabolism and Disposition, 2007

View PDFchevron_right